XRP Adoption Expands to 6,000 US Pharmacies
Wellgistics Health incorporates XRP into its payment system across 6,000 US pharmacies, backed by a $50 million equity line from LDA Capital.
- Wellgistics Health launches XRP payments in pharmacies.
- Enhances speed, liquidity, and transparency in healthcare.
- XRP serves as payment and treasury asset.
The implementation highlights growing institutional interest in cryptocurrency, providing faster and cost-effective transactions. It marks a significant real-world application of blockchain technology in the healthcare sector.
Wellgistics Health Initiative
The initiative by Wellgistics Health, supported by a $50 million line of credit from LDA Capital, aims to transform healthcare payments with XRP’s integration. Wellgistics will use XRP to enhance payment speed and liquidity for 6,000 US pharmacies.
Brian Norton, CEO of Wellgistics Health, emphasizes the integration of blockchain technology to improve payment systems. The decision positions Wellgistics Health as a pioneering entity in healthcare, optimizing financial operations with XRP as a core asset.
“Our blockchain-enabled payment system and ledger is just the next logical step in healthcare evolution, allowing us to hardwire speed, liquidity, and transparency into a system that’s long been starved of all three.” — Brian Norton, CEO of Wellgistics Health
Implications for the Healthcare Industry
The payment transformation is expected to deliver real-time settlement, boosting efficiency in transactions between pharmacies, suppliers, and manufacturers. This move reflects growing interest in incorporating cryptocurrencies in traditional sectors.
XRP’s cost-effective framework, with less than $0.0002 per transaction, provides a stark contrast to traditional wire fees. Its integration proves advantageous for liquidity and financial control within pharmacy networks.
The broader implications could lead to increased adoption of XRP and similar technologies within the healthcare industry. While concerns regarding regulatory approval exist, the strategy could offer essential cost benefits and propel technological advances.
This initiative demonstrates how blockchain, through XRP, may continue influencing financial systems and operational efficiency. It highlights a potential shift in pharmaceutical distribution towards more scalable and agile financial frameworks.
More From Crypto News
Ledger Unveils $849 Android-Based Atom Signer
Ledger has unveiled Atom, a new hardware signing device built on Android and priced at $849, marking the company’s latest push into the premium end of the crypt...
Binance Requires Full USDC Reserves for Stock Put Sellers
A stock put option gives the buyer the right to sell shares at a fixed strike price. The seller, or writer, takes the other side, accepting a possible obligatio...
Patrick Witt Confirms White House Exit as CLARITY Act Stalls
White House crypto negotiator Patrick Witt has confirmed his departure, with the exit arriving as the CLARITY Act faces a stalled path through Congress. Witt ha...
Bitcoin Recovers to $82,000 After $939M Crypto Liquidations
Bitcoin clawed back to around $82,000 after a sharp sell-off that triggered $939 million in crypto liquidations across derivatives markets, wiping out leveraged...
XRP Wallet Balances Rise 84M Tokens as Price Nears $1.30
Exchange-linked XRP wallet balances reportedly rose by 84 million tokens over a three-day window as the token’s price moved toward the $1. 30 level, according t...
Circle’s USDC EU Milestone Ahead of November Changes
Circle has become the first global stablecoin issuer to receive Electronic Money Institution (EMI) approval under the EU’s Markets in Crypto-Assets (MiCA) regul...
